Ube1L (UBA7) Rabbit Monoclonal Antibody [Clone ID: EPR4270]
Other products for "UBA7"
Specifications
Product Data | |
Clone Name | EPR4270 |
Applications | IF, WB |
Recommended Dilution | WB: 1:1000 - 1:10000; IP: 1:10 - 1:100; FC: 1:10 - 1:100; ICC/IF: 1:100 - 1:250 |
Reactivities | Human |
Host | Rabbit |
Isotype | IgG |
Clonality | Monoclonal |
Immunogen | A synthetic peptide corresponding to residues on the C-terminus in human UBA7 was used as an immunogen. |
Formulation | PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05% |
Conjugation | Unconjugated |
Storage | Store at -20°C as received. |
Stability | Stable for 12 months from date of receipt. |
Gene Name | ubiquitin like modifier activating enzyme 7 |
Database Link | |
Background | The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. UBA7 (ubiquitin-like modifier activating enzyme 7) is a member of the E1 ubiquitin-activating enzyme family. This protein is a retinoid target that triggers promyelocytic leukemia (PML)/retinoic acid receptor alpha (RARalpha) degradation and apoptosis in acute promyelocytic leukemia, where it is involved in the conjugation of the ubiquitin-like interferon-stimulated gene 15 protein. |
Synonyms | D8; UBA1B; UBE1L; UBE2 |
Note | Is unsuitable for IHC-P. |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Parkinson's disease, Ubiquitin mediated proteolysis |
Documents
Product Manuals |
FAQs |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.